Age-related differences in inflammatory biomarkers and acute kidney injury among hospitalized malaria patients in Luanda, Angola
DOI:
https://doi.org/10.66585/ohmi.2026.2.0026Keywords:
Malaria, inflammatory burden, acute kidney injury, older adults, Angola.Abstract
Malaria remains a leading cause of morbidity and mortality in sub-Saharan Africa; however, the clinical profiles of older adults with malaria are poorly characterized. Here, we investigated age-related differences in inflammatory burden and acute kidney injury (AKI) among hospitalized patients with malaria in Luanda, Angola. We conducted a cross-sectional study of 518 patients with malaria at two tertiary hospitals in Luanda, Angola, from January 2023 to December 2024. Logistic regression assessed associations between age group and inflammatory burden scores and AKI. Older adults (> 50 years) represented 9.8% of patients with malaria. After multivariable analysis, gender, ABO blood group, hemoglobin S (HbS), parasitemia, and AKI were not associated with age group (p > 0.05). In contrast, moderate [AOR: 0.40 (95% CI: 0.18–0.90), p = 0.028] and high inflammatory burden [AOR: 0.19 (95% CI: 0.04–0.91), p = 0.038] were associated with lower odds of being in the older age group. AKI was more frequent in older adults (35.3% vs 34.7%) and was associated with slightly increased odds (AOR: 1.09; p = 0.842), although this was not statistically significant. Patients over 50 years of age constituted a clinically distinct group among hospitalized malaria cases, characterized by a markedly reduced inflammatory response and a slight increase in acute kidney injury compared to younger patients, despite similar parasitemia. These findings highlight important age-related differences in the pathophysiology of malaria and reinforce the importance of including the elderly in targeted clinical and public health strategies in malaria-endemic areas.
References
1. World Health Organization. World malaria report 2023. Geneva: World Health Organization; 2023. Available from: https://www.who
.int/teams/global-malaria-programme/reports/world-malaria-report-2023. Accessed 2026 Jul 03.
2. Sacomboio ENM, Santos Sebastião C, Tchivango AT, Pecoits-Filho R, Calice-Silva V. Does parasitemia level increase the risk of acute kidney injury in patients with malaria? Results from an observational study in Angola. Sci Afr. 2020;7:00232. https://doi.org/10.1016/j.sciaf.2019.e00232
3. Loughland JR, Dooley NL, Pava Z, SheelaNair A, Andrew DW, Tipping P, et al. Age is an intrinsic driver of inflammatory responses to malaria. Nat Commun. 2025;16:8665. https://doi.org/10.1038/s41467-025-63638-1
4. Hashmi F, Aqeel S, Zuberi UF, Khan W. A systematic review and meta-analysis of inflammatory biomarkers associated with malaria infection and disease severity. Cytokine. 2023;169:156305. https://doi.org/10.1016/j.cyto.2023.156305
5. Mbengue M, Gaye AC, Tshabayembi J, Fall S, Sall I, Diouf M, et al. Prevalence, associated factors, and prognosis of acute kidney injury in severe malaria among Sub-Saharan Africans. G Ital Nefrol. 2025;42(4):35-43. https://doi.org/10.69097/42-04-2025-03
6. Plewes K, Royakkers AA, Hanson J, Hasan MMU, Alam S, Ghose A, et al. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria. Malar J. 2014;13:91. https://doi.org/10.1186/1475-2875-13-91
7. Kone AK, Sagara I, Thera MA, Dicko A, Guindo A, Diakite S, et al. Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali. Malar J. 2010;9:332. https://doi.org/10.1186/1475-2875-9-332
8. Sacomboio ENM, Campo LH, Daniel FN, Ekundi-Valentin E. Can vital signs indicate acute kidney injury in patients with malaria? Results of an observational study in Angola. Sci Afr. 2021; 14.e01021. https://doi.org/10.1016/j.sciaf.2021.e01021.
9. Sebastião CS, Cassinela E, Costa-Manuel V, Matary W, Nkuku M, Paciência I, et al. Dynamics of liver function among patients with malaria in Luanda, Angola: A cross-sectional study. Arch Clin Biomed Res. 2025;9(4):322-327. https://doi.org/10.26502/acbr.50170469
10. Gupta BK, Gupta A, Nehra HR, Balotia HR, Meena SL, Kumar S. Clinical profile and prognostic indicators in adults hospitalized with severe malaria caused by different Plasmodium species. Infect Dis (Auckl). 2015;8:45-50. https://doi.org/10.4137/IDRT.S34039
11. Igbeneghu C, Odaibo AB, Olaleye DO. Impact of asymptomatic malaria on some hematological parameters in the Iwo community in Southwestern Nigeria. Med Princ Pract. 2011;20(5):459-463. https://doi.org/10.1159/000327673
12. Arogundade FA, Hassan MO, Omotoso BA, Oguntola SO, Okunola OO, Sanusi AA, et al. Spectrum of kidney diseases in Africa: Malaria, schistosomiasis, sickle cell disease, and toxins. Clin Nephrol. 2016;86(1):53-60. https://doi.org/10.5414/CNP86S120
13. Sriboonvorakul N, Ghose A, Hassan MMU, Hossain MA, Faiz MA, Pukrittayakamee S, et al. Acidosis and acute kidney injury in severe malaria. Malar J. 2018;17(1):128. https://doi.org/10.1186/s12936-018-2274-9
14. Olwit G, Gutanamuka TB, Chris-Uchendu HC, Mugisha AI. Malaria-associated acute kidney injury: A key driver of mortality in endemic regions. Int J Nephrol Renovasc Dis. 2026;19:600266. https://doi.org/10.2147/IJNRD.S600266
15. Wu Q, Sacomboio E, Valente de Souza L, Martins R, Kitoko J, Cardoso S, et al. Renal control of life-threatening malarial anemia. Cell Rep. 2023;42(2):112057. https://doi.org/10.1016/j.celrep.2023.112057
16. Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561-1573. https://doi.org/10.1056/NEJMra1510865
17. Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: A review. Int J Infect Dis. 2010;14(1):2-12. https://doi.org/10.1016/j.ijid.2009.03.010
18. Williams TN, Obaro SK. Sickle cell disease and malaria morbidity: A tale with two tails. Trends Parasitol. 2011;27(7):315-320. https://doi.org/10.1016/j.pt.2011.02.004
19. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6):S398-S405. https://doi.org/10.1016/j.amepre.2011.09.013
Published
Issue
Section
License
Copyright (c) 2026 Cruz S. Sebastião, Joana Morais, Edson Cassinela, Maurício da Costa, Eduardo Ekundi-Valentim, Euclides Sacomboio (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
